Italy

06.03.2005

Milan - The Italian biopharmaceutical company BioXell SpA recently announced the appointment of Professor Peter van Brummelen to its Board of Directors. The independent consultant to the pharmaceutical industry worked previously as Vice President of Clinical Operations at Solvay Pharmaceuticals, Global Head of Clinical Pharmacology at Roche in Basel, and as Professor of Medicine at the Universities of Leiden and Basel. He also serves as a Director on the Board of Basilea Pharmaceutica in Switzerland and of IQ Corporation in The Netherlands.

Milan/Geneva – Italian drugmaker Newron Pharmaceuticals and its partner Merck Serono have failed to demonstrate that its investigational drug Safinamide provides a significant benefit as a treatment for advanced Parkinson’s...

Rome/Milan – Together with two Italian research institutes, British drug giant Glaxo­SmithKline has begun to develop a therapy for the heriditary immune defect ADA-SCID, which affects only 350 children worldwide. Fondazione...

Rome – When it comes to GMOs, the gap between Italy’s federal government and its regions that has marked the country for years is rapidly widening into a gulf. The latest rupture was on display at the October session of the...

Valletta – A new Life Sciences Park is to be created on the outskirts of Malta’s capital Valletta. The EUR20m project will provide space for companies operating in biotechnology and medical sciences. The park will be located in...

Verona – Scientists at Glaxo­SmithKline in Verona have discovered that specific neurons in the amygdala control how mice react to fear stimuli. When they switched off the so-called Type I cells in the animals’ amyg­dala, the mice...

San Michele all’Adige – The genetic code of the Golden Delicious apple has been deciphered. Led by Riccardo Velasco at the Edmund Mach Foundation in San Michele all’Adige in Italy’s Trentino province, a team of scientists from 20...

Rome/Sydney – A novel therapy based on Yttrium-90-loaded beads has been shown to be safe and effective in patients with inoperable colorectal cancer liver metastases (British Journal of Cancer 103: 324-331) in a phase II trial...

: It’s hard to be a pro-GMO campaigner in Italy. Since 2001, the regions there have not implemented the plans for coexistence that were suggested by a ministerial decree. Instead, there was a de facto Italian moratorium on GM...

Milan – One of Italy’s biggest biotech players wants to raise EUR58m to boost its pipeline of cancer therapies. The round will be closed on July 16th. With operating costs of EUR22.5m and a total loss of about EUR17m in 2009,...

Milan – Italian researchers have restored sight to blind patients using stem cells from the patients’ own bodies. In a study published by the New England Journal of Medicine (10.1056/NEJMoa0905955), scientists from Modena and...

Partner-Events

Stockholm (SE)

Wien (A)

Product of the week

BioShake Series

The BioShake series contains high-speed mixer and thermal mixer for small and very small volumes in microplates and reaction tubes and allows for the first time high precise and efficient mixing in the microliter scale for a wide range of applications. more